The global chemoinformatics market was valued at USD 3.88 billion in 2024 and is projected to grow from USD 4.49 billion in 2025 to around USD 16.69 billion by 2034, advancing at a CAGR of 15.71%. The software segment held the largest share at 41% in 2024, while services are set to grow at a CAGR of 9.5%. Chemical analysis accounted for over 30% of market revenue, with molecular modeling expected to expand at the fastest rate over the forecast period.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Chemoinformatics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Chemoinformatics Market, by Product Type
8.1.1. Software
8.1.1.1. Market Revenue and Forecast
8.1.2. Services
8.1.2.1. Market Revenue and Forecast
8.1.3. Others
8.1.3.1. Market Revenue and Forecast
9.1. Chemoinformatics Market, by Application
9.1.1. Chemical Analysis
9.1.1.1. Market Revenue and Forecast
9.1.2. Drug Discovery
9.1.2.1. Market Revenue and Forecast
9.1.3. Molecular Modeling
9.1.3.1. Market Revenue and Forecast
9.1.4. Regulatory Compliance
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product Type
10.1.2. Market Revenue and Forecast, by Application
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product Type
10.1.3.2. Market Revenue and Forecast, by Application
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product Type
10.1.4.2. Market Revenue and Forecast, by Application
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product Type
10.2.2. Market Revenue and Forecast, by Application
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product Type
10.2.3.2. Market Revenue and Forecast, by Application
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product Type
10.2.4.2. Market Revenue and Forecast, by Application
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product Type
10.2.5.2. Market Revenue and Forecast, by Application
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product Type
10.2.6.2. Market Revenue and Forecast, by Application
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product Type
10.3.2. Market Revenue and Forecast, by Application
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product Type
10.3.3.2. Market Revenue and Forecast, by Application
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product Type
10.3.4.2. Market Revenue and Forecast, by Application
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product Type
10.3.5.2. Market Revenue and Forecast, by Application
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product Type
10.3.6.2. Market Revenue and Forecast, by Application
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product Type
10.4.2. Market Revenue and Forecast, by Application
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product Type
10.4.3.2. Market Revenue and Forecast, by Application
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product Type
10.4.4.2. Market Revenue and Forecast, by Application
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product Type
10.4.5.2. Market Revenue and Forecast, by Application
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product Type
10.4.6.2. Market Revenue and Forecast, by Application
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product Type
10.5.2. Market Revenue and Forecast, by Application
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product Type
10.5.3.2. Market Revenue and Forecast, by Application
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product Type
10.5.4.2. Market Revenue and Forecast, by Application
11.1. ChemAxon
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. OpenEye Scientific Software
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. BIOVIA (Dassault Systèmes)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Schrödinger
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. PerkinElmer
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. CDD (Collaborative Drug Discovery)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. ACD/Labs
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. BioSolveIT
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Jubilant Biosys
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Genedata
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description